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Abstract A cDNA coding for a newly identified Bermuda grass 
pollen allergen, Cyn d 7, with significant sequence similarity to 
Ca2+-binding proteins, was isolated from a cDNA expression 
library using serum IgE from an allergic individual. The deduced 
amino acid sequence of Cyn d 7 contained two typical Ca2+-
binding sites (EF hand domains). Depletion of Ca2+ with EGTA 
led to a loss of IgE-binding capacity of rCyn d 7. A synthetic 
peptide based on domain II showed high IgE reactivity. Cyn d 7 
therefore represents a grass pollen allergen that belongs to a 
novel class of Ca2+-binding proteins. 
Key words: Cynodon dactylon; cDNA cloning; 
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1. Introduction 
Up to 20% of the human population in developed countries 
suffers from IgE-mediated atopic diseases such as allergic rhi-
nitis, conjunctivitis and bronchial asthma [1]. The major out-
door cause of allergy is airborne grass pollen [2]. In warm 
temperate and sub-tropical climates, such as northern and 
central Australia, Taiwan, southwestern United States and 
South Africa, Bermuda grass {Cynodon dactylon), is an impor-
tant source of allergens. In Australia, Bermuda grass flowers 
in summer and autumn extending the hayfever season from 
early spring, in which other grasses (i.e. rye-grass and canary 
grass) are considered to be the dominant source of pollen. 
Bermuda grass belongs to the sub-family Chloridoideae 
which is distantly related to other sub-families that contain 
clinically significant grasses. As a result, differences in the 
immunological reactivity of the allergens of Bermuda grass 
compared to other grasses have been noted in a number of 
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Abbreviations: 2LH, amino acid(s); Ab, antibody(ies); Bet v 3, major 
allergen(s) of birch pollen; Bet v 4, major allergen(s) of birch pollen; 
bp, base pair(s); BSA, bovine serum albumin; cDNA, DNA 
complementary to RNA; Cyn d 1, major allergen(s) of Bermuda grass 
pollen; Cyn d 7, major allergen(s) of Bermuda grass pollen; Ig, 
immunoglobulin(s); IUIS, International Union of Immunological 
Societies; Lol p 1, major allergen of rye-grass pollen; nt, nucleotide(s); 
ORF, open reading frame; PAGE, polyacrylamide gel electrophoresis; 
PBS, phosphate-buffered saline; PEG, poly(ethylene glycol); rCyn d 7, 
recombinant Cyn d 7; rBet v 4, recombinant Bet v 4; SDS, sodium 
dodecyl sulfate. 
The nucleotide and amino acid sequences of Cyn d 7 have been 
submitted to the EMBL and Genbank databases under the accession 
numbers X91256 and U35683, respectively. 
studies [3-5]. Moreover, individuals allergic to Bermuda grass 
require separate diagnosis and treatment [6]. Therefore, mo-
lecular and immunological characterisation of Bermuda and 
other grass pollen allergens are of paramount importance in 
order to gain a better insight into the molecular basis of 
allergenicity and provide material for possible use in the fu-
ture treatment of grass pollen allergy. 
We have cloned and characterized the genes encoding the 
major allergens of two clinically important grasses; Lol p 1 
from rye-grass [7] and Cyn d 1 from Bermuda [8]. Although 
comparison of the deduced amino acid sequences of Cyn d 1 
and Lol p 1 indicates a significant degree of identity (64.2%), 
their immunological reactivities are different. Some individu-
als have IgE that recognises Lol p 1 but does not recognise 
Cyn d 1 [8]. 
Although the major allergens from most of the clinically 
significant grass pollens have been cloned and their immuno-
logical properties characterised, no information is available 
regarding the biological function of these proteins. However, 
one example of a well described pollen allergen from the birch 
tree is profilin, an actin-binding protein [9-11]. Since profilin 
is suggested to be involved in the acrosomal reaction of 
Thyone sperm [12,13] and also predominantly expressed in 
the pollen of different unrelated plant species, it is likely 
that profilins play important roles in plant sexual reproduc-
tion and in particular in pollen germination [10]. It is well 
established that pollen germination and tube growth are de-
pendent on the presence of Ca2+ ions and the intracellular 
levels and the distribution of Ca2+ is tightly controlled by 
Ca2+-binding proteins such as calmodulin [14,15] and such 
Ca2+-binding proteins have been recently identified as aller-
gens in birch tree pollen [16]. Therefore, the occurrence of 
similar protein allergens in pollens of distantly related plants 
(i.e. birch tree and Bermuda grass) deserves further study. 
In this paper, we report the cDNA sequence and immuno-
logical characterisation of a novel Bermuda grass pollen aller-
gen, designated Cyn d 7, as a Ca2+-binding protein. This is 
the first cloned grass pollen allergen with a known biological 
function. Furthermore, a synthetic peptide based on the se-
quence of Ca2+-binding domain II showed high IgE reactivity, 
highlighting the importance of the Ca2+ domain in allergenic-
ity and its possible role in human autoimmunity in allergy to 
pollens of distantly related plants. Ca2+-binding proteins serve 
as receptors for calcium signals in plant and animal cells. Such 
a signalling function may be important in determining the 
allergenicity of this protein. On the other hand, cloning of 
this allergen will make a significant contribution to defining 
allergens and providing material and information for B cell 
epitope and T cell studies. It is anticipated that its usefulness 
could extend into developing reagents to improve diagnosis 
and immunotherapy of grass pollen allergy. 
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2. Materials and methods 
2.1. Isolation and sequencing of cDNA clones 
Total RNA was extracted from mature anthers of Bermuda grass 
(Cynodon dactylon (L.) Pers.) using the method of Chomczynski and 
Sacchi [17]. Polyadenylated RNA was isolated using an oligo(dT) 
affinity column (Pharmacia, Sweden) and cDNA library constructed 
in \gtll expression vector using a Time-Saver cDNA synthesis kit 
(Pharmacia, Sweden). Immunological screening was performed by 
probing duplicate niters with sera from Bermuda grass pollen allergic 
individuals. The positive clones were identified using rabbit anti-hu-
man IgE antibodies (DAKO, USA) followed by horseradish peroxi-
dase-conjugated anti-rabbit immunoglobulin (Promega, USA). The 
cDNA inserts recovered from positive clones were ligated into plasmid 
vector, pBluescript KS(+) (Stratagene, USA). DNA sequencing was 
performed on double-stranded DNA by the dideoxy chain-termina-
tion method using a T7 DNA sequencing kit (Pharmacia, Sweden). 
Specific oligonucleotide primers were used to obtain the complete 
sequence along both strands. Sequence analysis, including aa deduc-
tion, was performed using the computer program DNA Strider (Com-
missariat a l'Energie Atomique, France). The nt and aa sequences of 
Cyn d 7 were searched for comparison with other sequences in the 
Angis database which incorporates databases from the following ma-
jor sources: GenBank, EMBL and NBRF nucleic acid libraries; 
NBRF PIR protein and Swiss-Prot libraries. The nt and deduced aa 
sequences of the Cyn d 7 cDNA have been submitted to the EMBL 
and GeneBank databases under the accession numbers X91256 and 
U35683, respectively. 
2.2. Expression and immunological analysis 
Immunological screening was accomplished as described by Suphio-
glu and Singh [18]. Briefly, A,gtll Cyn d 7 clones were plated and 
fusion protein plaque lifts were taken on Hybond-C extra nitrocellu-
lose membranes (Amersham, UK). Filter sectors were either incubated 
in serum only (diluted 1:4 in S buffer: PBS, 0.5% BSA), serum in the 
presence of CaCl2 (S buffer containing 10 mM CaCy or serum in the 
presence of EGTA (S buffer containing 10 mM EGTA, pH 7.5). IgE-
binding was detected using 125I-anti-human IgE (Kallestad, USA) as 
described by Suphioglu et al. [19]. 
2.3. Peptide synthesis and immunological analysis 
Two 12-mer peptides, based on the deduced aa sequences of do-
mains I and II of Cyn d 7 shown in Fig. 1, were synthesised on an 
automated Advanced ChemTech Multiple Peptide Synthesiser model 
MPS 350 (Advanced ChemTech, USA) employing Fmoc chemistry. 
The peptides were assembled sequentially on C-terminal Fmoc-pro-
tected aa WANG resins (25 uM; Auspep; Australia). Briefly, the aa 
was deprotected by piperidine (25% in DMF; Auspep; Australia), 
washed seven times with DMF (Auspep; Australia), coupled twice 
with the next aa residue for 30 min each in presence of HOBt and 
DIC (Auspep; Australia), washed three times with DMF, and the 
same steps repeated sequentially until the assembly of all aa were 
completed. After final deprotection, the resin was washed three times 
with absolute ethanol and dried overnight at 35°C under vacuum. The 
dried resins were incubated in cleaving solution (95% TFA, 4% phe-
nol, 1% ETT; Auspep; Australia) for 6 h at room temperature 
(~ 18°C) and the cleaved peptides precipitated in ice-cold DEE (Aus-
pep; Australia) for 30 min. Precipitated peptides were isolated on 
qualitative filter paper no. 1 (Whatman, UK) and eluted with 30% 
acetonitrile in water and then freeze-dried. The lyophilised peptides 
were resuspended in distilled water to give a 1.6 mM stock solution 
and analysed by FPLC (Pharmacia, Sweden) and mass spectrometry 
to check mass, sequence and purity. The peptides were immobilised 
onto NC filters (BA 0.45 um, Schleicher and Schuell, Germany) by 
using a modified method of Sithigorngul et al. [20]. 2 ul drops of the 
peptide stock solutions were spotted on the NC filters about 1 cm 
apart. After the strips were dried and baked at 80°C for 1 h, they were 
fixed by exposure, in a tightly sealed plastic box, to vapor from 0.2% 
glutaraldehyde (Serva Feinbiochemica GmbH and Co., Germany) in 
PBS at 37°C overnight followed by fixation in fresh 2% glutaralde-
hyde in PBS at room temperature for 1 h. After washing thoroughly 
with distilled water, the NC filters were blocked, washed, screened for 
IgE-binding and detected with 125I-labelled anti-human IgE, as de-
scribed in Section 2.2 above. 
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2.4. Inhibition studies 
Expression plasmid containing the Bet v 4 cDNA was constructed 
in the vector pMW175 [21] which is based on the original pET vectors 
of Studier et al. [22]. For expression of the pMW175/Bet v 4 plasmid, 
competent E. coli strain BL21(DE3) was transformed and selected on 
plates containing 100 mg/1 ampicillin [22]. A single transformant col-
ony was picked and grown to an OD60o of 1.0. Isopropyl-P-D-thio-
galactopyranoside was then added to a final concentration of 1.0 mM, 
and incubation continued for 6 h at 37°C. After expression, cells were 
harvested by centrifugation, and pellets resuspended in 50 mM Tris-
HC1, pH 7.5 containing 220 mM NaCl. Cells were then disrupted by 
freezing in liquid nitrogen followed by thawing at 37°C. This step was 
repeated twice. rBet v 4 was recovered in the supernatant after cen-
trifugation at 30000Xg for 25 min at 4°C. rBet v 4 was purified from 
crude E. coli lysates by chromatofocusing on a PBE-94 (Pharmacia, 
Sweden) exchanger column and reverse-phase HPLC, as previously 
described [23]. Briefly, bacterial lysates were prepared in 25 mM imi-
dazole-HCl buffer, pH 7.4. After treatment with Biocryl BPA-1000 
(Tosohaas, Stuttgart, Germany) and centrifugation, the clear super-
natant was loaded onto a PBE-94 exchanger column equilibrated with 
imidazole buffer, at room temperature. Bound proteins were eluted 
with aqueous 12.5% (v/v) Polybuffer 74/HC1 (Pharmacia), pH 4.0. 
Fractions containing Bet v 4, as determined by dot-blot IgE immuno-
assay, were pooled and subjected to HPLC employing a linear gra-
dient of 2-propanol created within 60 min at room temperature (C8 
Hypersil-WP 300 column, 10 mm, 8x250 mm; solvent A: 0.1% tri-
fluoroacetic acid in water; solvent B: 90% 2-propanol, 0.1% trifluoro-
acetic acid; gradient of 0-60% solvent B; flow rate 1.0 ml/min). As 
Bet v 4 contains no tryptophan, tyrosine, or cysteine residues, UV 
absorbance was monitored at 214 nm. Protein concentration was de-
termined by the micro-Kjeldahl method using glycine as standard [24]. 
Protein plaque lifts of Cyn d 7 were prepared as described in Sec-
tion 2.2. Filter sectors were incubated in serum only (diluted 1:4 in S 
buffer: PBS, 0.5% BSA), serum pre-incubated for 1 h with 100 ug 
peptide 1, 100 jig peptide 2 or 100 \ig rBet v 4. IgE-binding was 
detected as described in Section 2.2 above. 
3. Results and discussion 
3.1. Molecular cloning and characterisation of Cyn d 7 
A mature Bermuda grass anther A,gtll cDNA expression 
library was screened with pooled sera of grass pollen allergic 
patients. Four clones that bound strongly to IgE antibodies 
(Ab) were identified and plaque-purified. The purified clones 
gave no signal when screened with non-allergenic human sera. 
The ability to bind to specific IgE Ab in sera of grass pollen 
sensitive individuals identified these clones as encoding aller-
gens. Consequently, all four clones were transformed into 
plasmid vectors and their nucleic acid sequences determined. 
The sequences of three clones could not be identified with any 
protein of known function in the databases. The deduced aa 
sequence of the other cDNA, clone E3, when compared with 
sequences in EMBL and Swiss-Prot databases revealed a sig-
nificant sequence similarity with calcium-binding proteins in-
cluding the birch pollen allergen Bet v 4 (Fig. 1). Moreover, 
there was a strict conservation of aa residues representing the 
two calcium-binding domains (Fig. 1). The deduced aa se-
quence identities between Cyn d 7 and other calcium-binding 
proteins ranged from 32.9% (with A. thaliana touch-induced 
calmodulin-related protein 3, calmodulin from the fungus F. 
oxysporum and S. dubia mRNA for caltractin) to 66% (Bet v 
4) (Table 1). However, in all cases the highest sequence sim-
ilarities were observed with the calcium-binding domains (e.g. 
83.3%> between domains I and II of Cyn d 7 and Bet v 4). The 
sequence of clone E3 contains an ORF of 246 bp encoding a 
mature protein of 82 aa ( ~ 9 kDa). Clone E3 was conse-
quently named Cyn d 7 in accordance with IUIS nomencla-
ture [25]. 
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Cyn d 7 
Bet v 4 
B34669 
ATHACR 
CATR_T 
CELC24 
MCZP 
CATR_C 
CALM_C 
JU0232 
SDCALT 
Cyn d 7 
Bet v 4 
B34669 
ATHACR 
CATR_T 
CELC24 
MCZP 
CATR_C 
CALM_C 
JU0232 
SDCALT 
--Domain I--
KTMADT GDMEHIFKRFDTNGDGKISLAELTDALRTLG-STSAD 
DHPQDK AERERIFKRFDANGDGKISAAELGEALKTLG-SITPD 
LTDDQITEYKESFRLFDKNGDGSITKKELGTVMRSLGQNP'TKA 
KTMADKLTDDQITEYRESFRLFDKNGDGSITKKELRTVMFSLGKNRTKA 
LTEEQKQDIREAFDLFDTDGSG7IDAKELKVAMRAEGFEPKKE 
VGEIREDDLKGIFREFDLNGDGYIQREELRAVMQKMGQSPTED 
RKMKD TDNEEEVREAFKVFDKDGNGYITVEELTHVLTSLGERLSQE 
LTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKE 
RKMKD TDSEAEIAEAFKVFDRNGDGKISAAELRHLLTSIGEKLSDA 
RKMKD TDSEEEIREAFKVFDRDNDGFISAAELRHVMTSIGEKLTDD 
LTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKE 
En nn n# # #G I* #n nn n 
120 
119 
XXXXXXXXX+ + +///////// 
--Domain II-
EVQRMMAEIDTDGDGFIDFDEFISFCNANPGLMKDVAKVF 
EVKHMMAEIDTDGDGFISFQEFTDFGRANRGLLKDVAKIF 
DLQDMMNEVDLDGDGTIDFPEFLKLMA 
DLQDMMNEVDLDGDGTIDFPEFLYLMAKNQGHDQAPRHTK 
EIKKMIADIDKDGSGTIDFEEFLQMMTAKMGERD3REEIM 
ELDAMFQAADKDCDGNIDFQEFLVIAKANPLSLSLKAVFE 
EVADMIREADTDGDGVINYEEFSRVISSK 
EIKKMISEIDKDGSGTIDFEEFLTMMTAKMGERDSREEIL 
DVDQMIKEADTNNDGEIDIQEFTSLLAAK 
EVDEMIREADQDGDGRIDYNEFV Q 
EIKKMIADIDKDGSGTIDFEEFLQMMTAKMGERDSREEIM 
En nn n# # #G I# #n nn n 
150 
104 
149 
143 
XXXXXXXXX+ + *l11111111 
Fig. 1. Comparison of Cyn d 7 with other proteins in the EMBL 
and Swiss-Prot databases exhibiting calcium-binding domains. Bet v 
4: Be tula verrucosa pollen allergen (Engel et al., unpublished; acces-
sion no. S54819); B34669: Arabidopsis thaliana touch-induced cal-
modulin-related protein 3 (accession no. B34669 [37]); ATHACR: 
Arabidopsis thaliana calmodulin-related protein (TCH3) gene (acces-
sion no. L34546 [38]); CATR_T: caltractin (centrin) from green al-
gae Tetraselmis striata (accession no. P43646 [39]); CELC24: EF-
hand calcium-binding protein from Caenorhabditis elegans cosmid 
(accession no. U40423 [40]); MCZP: calmodulin from the yeast 
Schizosaccharomyces pombe (accession no. A26614 [41]); CATR_C: 
caltractin (centrin) from green algae Chlamydomonas reinhardtii (ac-
cession no. P05434 [42]); CALM_C: calmodulin from the yeast 
Candida albicans (accession no. P23286 [43]); JU0232: Calmodulin 
from the fungus Fusarium oxysporum (Hoshino et al., unpublished; 
accession no. JU0232); SDCALT: Scherjfelia dubia mRNA for cal-
tractin (accession no. X69220 [39]). The two calcium-binding do-
mains are indicated by + and the residues predicted to ligand calci-
um is shown by # ; stars (■*•) indicate identical residues and dots (.) 
similar ones. Amino acids said to be similar are: A,S,T; D,E; N,Q; 
R,K; I,L,M,V; F,Y,W. Numbers to the right of the sequence refer 
to the amino acid residue numbers of each protein. Gaps repre-
sented by dashes (-) have been introduced to ensure maximum ho-
mology. The EF-hand model position numbers are from Kretsinger 
[44] with residues represented by X, + and / corresponding, respec-
tively, to the E helix, calcium-binding loop, and F helix of the calci-
um-binding domains. The amino acids indicated by n are predicted 
to be on the hydrophobic face of the a-helices in calcium-binding 
proteins. The glutamic acid (E), the glycine (G) and the isoleucine 
(I) in the calcium-binding proteins are also conserved in Cyn d 7 ex-
cept in domain I where glutamic acid (E) is replaced with a similar 
amino acid aspartic acid (D). The nt and deduced aa sequences of 
the Cyn d 7 cDNA have been submitted to the EMBL and Gene-
Bank databases under the accession numbers X91256 and U35683, 
respectively. 
> 36% of the 30 sera tested (Fig. 2). When IgE, specific to a 
partial clone of Cyn d 7, was eluted off from the plaque lifts 
and used to screen a Western blot of SDS-PAGE resolved 
crude Bermuda grass pollen extract, a 12 kDa protein bound 
these Ab [26]. Similarly, after incubation of the Cyn d 7 pro-
tein plaque lifts in the same serum, IgE specific for the 12 kDa 
protein was depleted from the serum [26]. These results sug-
gest that this 12 kDa protein represents natural Cyn d 7. 
It has been reported that the binding of monoclonal anti-
bodies raised against calmodulin requires Ca2+ [27] and that 
depletion of Ca2+ from recombinant birch pollen allergen Bet 
v 3 led to a loss of IgE-binding capacity [16]. We therefore 
tested whether the binding of allergenic patients' IgE is af-
fected by addition and depletion of protein-bound Ca2+ using 
EGTA. Fig. 2 shows that while addition of Ca2+ slightly 
enhanced IgE reactivity, depletion of Ca2+ from rCyn d 7 
led to an almost complete loss of the IgE-binding capacity. 
In order to investigate whether the two Ca2+-binding do-
mains represent IgE epitopes, we produced synthetic peptides 
(12-mers) representing the two domains and tested their IgE-
binding capacity. Although peptide 1 (based on aa sequence 
of domain I) did not bind IgE, peptide 2 (based on aa se-
quence of domain II) showed strong IgE binding, and this 
binding could be significantly inhibited with the addition of 
free peptide 2 (Fig. 3). However, IgE binding to peptide 2 was 
not Ca2+ dependent since neither the addition of Ca2+ nor 
Genes encoding major pollen allergens from rye-grass and 
Bermuda grass show pollen-specific expression [7,8]. Using 
RNA gel blot analysis, a partial clone of Cyn d 7 hybridised 
to a transcript of approx. 900 nucleotides in pollen RNA but 
no transcripts were detectable in RNA from other Bermuda 
grass tissues [26]. Moreover, the same clone of Cyn d 7 
hybridised to transcripts in pollen of 13 other clinically sig-
nificant grasses [26], suggesting that Cyn d 7 and related pro-
teins play an important role in grass pollen development. 
3.2. Immunological characterisation of Cyn d 7 protein 
When recombinant fusion protein of Cyn d 7 was expressed 
in bacteria as plaque lifts and screened with sera from grass 
pollen allergic individuals, IgE binding was observed among 
Fig. 2. Effect of protein-bound Ca2+ on the IgE-binding capacity of 
Cyn d 7. Plaque lift nitrocellulose sectors containing rCyn d 7 (A-
C) or non-recombinant Xgtll control (D) were incubated with se-
rum IgE from a Bermuda grass pollen allergic individual (I) or with 
serum IgE from a non-allergic individual (II). Filters were incubated 
either in serum only (A,D), or serum in the presence of CaCl2 (B) 
or EGTA (C). 
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depletion of Ca2+ with EGTA generate a significantly differ-
ent IgE-binding intensity to that shown in Fig. 3A (data not 
shown). This suggests that IgE binding may be directed to 
specific amino acid residue(s) that, unlike our observations 
for rCyn d 7, does not require Ca2+ for binding. In a similar 
study with Bet v 3 from birch pollen, Seiberler et al. [16], 
could not detect any IgE binding when inhibited with syn-
thetic peptides based on all three calcium-binding domains 
of Bet v 3. As may be the case with our peptide 1, the lack 
of IgE binding to the three peptides of Bet v 3 may imply that 
the IgE-binding epitopes represented by these peptides may be 
conformational within the context of the natural folded pro-
tein. Indeed, while the SDS-PAGE resolved natural Cyn d 7 
can be identified with affinity purified IgE antibodies specific 
to rCyn d 7, Seiberler et al. [16] reported that although rBet v 
3, as plaque lifts, binds IgE, no IgE binding could be detected 
under the denaturing conditions of SDS-PAGE, indicating 
that the binding of allergenic patients' IgE might depend on 
the natural conformation of Bet v 3. However, it should also 
be stressed here that IgE-reactive, recombinant proteins, espe-
cially fusion proteins like Cyn d 7 and Bet v 3, are unlikely to 
mimic the natural conformation of these proteins. Despite 
this, natural Cyn d 7 can be identified with rCyn d 7-specific 
IgE Ab [26] indicating the presence of the recombinant epit-
opes within the context of the natural protein. 
3.3. Immunological cross-reactivity between Cyn d 7 and Bet v 
4 proteins 
A major birch pollen allergen, Bet v 3, has been recently 
characterised as a Ca2+-binding protein [16]. Unlike Cyn d 7, 
Bet v 3 has three calcium-binding domains and is a larger 
protein. On the other hand, a search of the EMBL and 
Swiss-Prot databases revealed a strong sequence similarity 
with another recently cloned Ca2+-binding allergen from birch 
pollen, designated as Bet v 4. Bet v 4 is not only similar to 
Cyn d 7 in molecular mass but also shares two similar Ca2+-
binding domains (Fig. 1). 
In order to assess whether Bet v 4 and Cyn d 7 were im-
munologically cross-reactive, we performed antibody deple-
tion experiments (Fig. 4). Here, we have screened Cyn d 7 
plaque lifts with serum from a Bermuda grass pollen allergic 
individual either in the absence or presence of purified rBet v 
4, as the competing protein. Fig. 4 clearly shows that Bet v 4 
has the capacity to compete with Cyn d 7 for the same IgE Ab 
Fig. 3. IgE reactivity of synthetic peptides based on Ca2+-binding 
domain I (PI) and domain II (P2) of Cyn d 7. (A) Peptides 
screened with serum of a Bermuda grass pollen allergic individual 
only. (B) Peptides screened with the same serum pre-incubated with 
100 |xg of P2. (C) Peptides screened with serum from a non-allergic 
individual. 
and thus must be immunologically similar or cross-reactive. 
Plaque lifts screened under the same conditions using serum 
from a non-allergic individual indicated no binding. 
In a further study, addition of peptide 2 (based on domain 
II) to allergic patient serum gave a significant reduction in IgE 
Ab binding to Cyn d 7 plaque lifts (Fig. 4). Moreover, when 
the aa sequences representing domain II of Cyn d 7 and Bet v 
4 are compared there is a very high sequence identity ( > 83%) 
(Table 1); the two different aa residues at positions 60 and 62 
of Cyn d 7 sequence can thus be considered as not critical for 
IgE-binding. However, peptide 1 (based on domain I) has 
similar aa sequence identity ( > 83%) (Table 1) but did not 
show any inhibitory effect on IgE-binding. These results 
clearly indicate that Ca2+-binding domain II is also an aller-
genic epitope in Cyn d 7 and Bet v 4 and must exist as a linear 
epitope within the context of the folded natural proteins. On 
the other hand, the lack of IgE-binding and competitive effect 
of peptide 1 on IgE-binding reactivity of Cyn d 7 indicates 
that this domain does not represent an allergenic epitope or 
may be conformational in nature within the context of the 
folded natural protein. 
3.4. Clinical and biological significance of Cyn d 7 protein 
This is the first report of the molecular cloning and char-
acterisation of a Ca2+-binding allergen from grass pollen and 
the cloning of a grass pollen allergen with a known biological 
Table 1 
Percentage identity between the deduced aa sequence of Cyn d 7 and other calcium-binding proteins as shown in Fig. 1 
Proteins 
Bet v 4 
Touch-induced calmo-
dulin-related protein 3 
Calmodulin-related 
protein (TCH3) 
Caltractin (centrin) 
EF-hand calcium-
binding protein 
Calmodulin 
Caltractin (centrin) 
Calmodulin 
Calmodulin 
Caltractin 
Source 
Betula verrucosa 
Arabidopsis thaliana 
Arabidopsis thaliana 
Tetraselmis striata 
Caenorhabditis elegans 
Schizosaccharomyces pombe 
Chlamydomonas reinhardtii 
Candida albicans 
Fusarium oxysporum 
Scherffelia dubia 
Data-base 
name 
Bet v 4 
B34669 
ATHACR 
CATR T 
CELC24 
MCZP 
CATR C 
CALM C 
JU0232 
SDCALT 
% aa sequence 
identity with 
Cynd 7 
65.9 
32.9 
40.2 
35.4 
36.6 
35.4 
34.1 
39 
32.9 
32.9 
% aa sequence identity 
with domain I 
of Cyn 
83.3 
48.3 
58.3 
50 
58.3 
41.7 
50 
83.3 
58.3 
50 
d 7 
% aa sequence identity 
with domain II 
of Cyn d 7 
83.3 
75 
75 
66.7 
66.7 
66.7 
66.7 
58.3 
66.7 
66.7 
References for the proteins are listed in Fig. 1. 
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Fig. 4. Assessment of immunological cross-reactivity between rCyn 
d 7 and rBet v 4 from birch pollen. Protein plaque lifts of Cyn d 7 
probed with serum from a Bermuda grass pollen allergic individual 
only (A); serum pre-incubated with 100 ug peptide 1 (based on do-
main I) (B); serum pre-incubated with 100 ug peptide 2 (based on 
domain II) (C); serum pre-incubated with 100 ug rBet v 4 (D); se-
rum from a non-allergic individual (E). 
function. Allergens of similar sequence structures and biolog-
ical functions have been characterised in birch pollen (i.e. Bet 
v 3 and Bet v 4). However, although birch is botanically dis-
tantly related to Bermuda grass, evidence of the similarities 
between Cyn d 7 and Bet v 4 highlight the presence of strict 
conservation of certain genes through evolution. 
There is very significant similarity between Cyn d 7 and 
other Ca2+-binding calmodulins. Calmodulin is a highly con-
served protein found in all eukaryotes with 98% similarity 
between vertebrates and plants [28]. The low level of similarity 
between Cyn d 7 and other plant calmodulins suggests that 
Cyn d 7 may not encode calmodulin itself. However, the high 
level of identity with the Ca2+-binding domain of calmodulin 
suggests that Cyn d 7 may encode calmodulin-related Ca2+-
binding proteins. Indeed, this type of protein has been iden-
tified in mammals [28]. Calmodulin acts as a second messen-
ger in many systems, binding Ca2+ and then interacting with 
enzymes to activate them. Calmodulin has been implicated in 
such important functions as mitosis [29], induced microtubule 
dissociation [30] and in pollen tube growth where it may be 
associated with the microfilament network and be involved in 
vesicle transport and cytoplasmic streaming [31]. Indeed, re-
cent works have shown that tip-focused Ca2+ gradient is 
present in pollen tubes of Agapanthus [32], Lilium, Tradescan-
tia and Nicotiana [33]. Therefore, since Ca2+-binding proteins 
may have similar functions to those of calmodulin and tran-
scripts similar to Cyn d 7 have been found in other grasses 
examined [26], we suggest that Cyn d 7 may play a pivotal 
role as a messenger in grass pollen development and especially 
in pollen tube growth with tip-focused Ca2+ gradients. Now 
that we have cDNA clones that encode Cyn d 7, we are 
interested in the localisation of Cyn d 7 in the germinating 
pollen; especially the tip of pollen tubes. 
In terms of clinical importance, a number of low Mr aller-
gens from Bermuda grass pollen have been previously identi-
fied but not fully characterised [34,35] and it is possible that 
the protein encoded by Cyn d 7 corresponds to one of these. 
Since allergens with significant similarity to calmodulin have 
also been recently identified in birch pollen [16], it may be 
possible that these Ca2+-binding proteins are ubiquitous pro-
teins like manganese Superoxide dismutase from Aspergillus 
fumigatus which has been recently shown to have in vitro 
and in vivo humoral and cell-mediated autoimmune reactivity 
to human manganese Superoxide dismutase in individuals al-
lergic to A. fumigatus [36]. 
We have demonstrated in this study the occurrence of cross-
reactivity and shared IgE-binding epitopes between Cyn d 7 
and Bet v 4. An exciting feature of this study has been the 
finding that Ca2+-binding domain II shows high IgE reactivity 
whereas domain I does not. It will be important in future 
work to immunodissect domain II further in terms of its 
Ca2+ binding and the apparent co-occurrence of IgE-binding 
by amino acid replacement studies. The availability of highly 
purified Cyn d 7, whether natural, recombinant or synthetic, 
will be useful in standardisation of allergen extracts for both 
diagnosis and treatment of allergies triggered by Ca2+-binding 
proteins. 
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